Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R HAY

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Parkinsonism & Related Disorders|April 13, 2024
Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's diseaseDavid A Isaacs, Kaitlyn R Hay, Jennifer Hoadley, et al.
Biopreservation and Biobanking|October 17, 2018
Further Evidence That the Genebank Standards for Drying Orthodox Seeds May Not Be Optimal for Subsequent Seed LongevityKatherine J Whitehouse, Olorunnisola F Owoborode, Olufemi O Adebayo, et al.
Journal of Periodontology|March 1, 1991
Monoclonal antibodies to periodontal ligament cellsW T DuBois, J Edmondson, S B Milam, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 19, 2024
Apathy and Functional Status in Early-Stage Huntington's DiseaseJessie S Gibson, Kaitlyn R Hay, Daniel O Claassen, et al.
The New Zealand Medical Journal|May 11, 1983
Coronary heart disease: prevention and control in 1983D R Hay, R Beaglehole, J F Gwynne, et al.
Harmful Algae|June 26, 2015
Factors regulating excystment of <i>Alexandrium</i> in Puget Sound, WA, USAStephanie K Moore, Brian D Bill, Levi R Hay, et al.
British Journal of Clinical Pharmacology|January 1, 1988
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarinI A Choonara, R G Malia, B P Haynes, et al.
Mycoses|December 3, 2003
High prevalence of foot diseases in Europe: results of the Achilles ProjectT Burzykowski, G Molenberghs, D Abeck, et al.
Seminars in Hematology|April 1, 1994
Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effectsC R Hay, J N Lozier, C A Lee, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Parkinsonism & Related Disorders|April 13, 2024
Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's diseaseDavid A Isaacs, Kaitlyn R Hay, Jennifer Hoadley, et al.
Biopreservation and Biobanking|October 17, 2018
Further Evidence That the Genebank Standards for Drying Orthodox Seeds May Not Be Optimal for Subsequent Seed LongevityKatherine J Whitehouse, Olorunnisola F Owoborode, Olufemi O Adebayo, et al.
Journal of Periodontology|March 1, 1991
Monoclonal antibodies to periodontal ligament cellsW T DuBois, J Edmondson, S B Milam, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 19, 2024
Apathy and Functional Status in Early-Stage Huntington's DiseaseJessie S Gibson, Kaitlyn R Hay, Daniel O Claassen, et al.
The New Zealand Medical Journal|May 11, 1983
Coronary heart disease: prevention and control in 1983D R Hay, R Beaglehole, J F Gwynne, et al.
Harmful Algae|June 26, 2015
Factors regulating excystment of <i>Alexandrium</i> in Puget Sound, WA, USAStephanie K Moore, Brian D Bill, Levi R Hay, et al.
British Journal of Clinical Pharmacology|January 1, 1988
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarinI A Choonara, R G Malia, B P Haynes, et al.
Mycoses|December 3, 2003
High prevalence of foot diseases in Europe: results of the Achilles ProjectT Burzykowski, G Molenberghs, D Abeck, et al.
Seminars in Hematology|April 1, 1994
Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effectsC R Hay, J N Lozier, C A Lee, et al.
Pageof 28